Seroquel (quetiapine) is an atypical antipsychotic medication approved to treat three main psychiatric conditions: schizophrenia, bipolar disorder, and major depressive disorder (as an add-on therapy). It’s also one of the most commonly prescribed psychiatric medications for off-label uses, particularly insomnia, though the evidence behind some of those uses is thin.
How Seroquel Works in the Brain
Seroquel blocks the activity of several chemical messengers in the brain, most importantly dopamine and serotonin. Its therapeutic effects in psychosis and mood disorders come primarily from dampening overactive dopamine signaling while also blocking certain serotonin receptors. This dual action is what makes it an “atypical” antipsychotic, distinguishing it from older antipsychotics that target dopamine alone. The broader receptor profile is also why Seroquel causes significant sedation, which explains its widespread off-label use as a sleep aid.
Schizophrenia
Seroquel is approved to treat schizophrenia in adults and in adolescents aged 13 to 17. For adults, the target dose typically falls between 150 and 750 mg per day, while the maximum licensed dose reaches 750 mg. The 2025 INTEGRATE international guidelines, a consensus effort involving psychiatric experts from all UN regions, position quetiapine as a standard first-line option for first-episode psychosis. The recommended approach starts low (around 50 mg) and increases over several days, reaching a target of 400 mg daily, with further increases to 600 mg if symptoms persist after two weeks.
The guidelines also highlight some specific situations where Seroquel may be especially useful. For patients who develop tardive dyskinesia (involuntary repetitive movements) on another antipsychotic, a switch to quetiapine is one of the recommended options. The same goes for akathisia, a distressing feeling of inner restlessness that some antipsychotics cause. On the downside, quetiapine has higher anticholinergic activity than many alternatives, which can contribute to cognitive dulling, dry mouth, and constipation.
Bipolar Disorder
Seroquel is approved for multiple phases of bipolar disorder, and the dose varies considerably depending on whether it’s being used for mania, depression, or long-term maintenance.
Bipolar Mania
For manic episodes in adults, the recommended dose ranges from 400 to 800 mg per day, split into two daily doses. Treatment ramps up quickly, starting at 100 mg on day one and reaching 400 mg by day four. For children and adolescents aged 10 to 17, the dose range is slightly lower at 400 to 600 mg per day, with a slower initial ramp-up starting at 50 mg per day.
Bipolar Depression
The dosing for depressive episodes looks quite different. The target is just 300 mg per day, taken once at bedtime. This lower dose reflects the fact that Seroquel’s antidepressant and mood-stabilizing properties kick in at doses well below what’s needed to manage psychosis or mania.
Maintenance Therapy
For long-term prevention of mood episodes in bipolar I disorder, Seroquel is approved at 400 to 800 mg per day as an add-on to lithium or another mood stabilizer. Patients generally stay on whatever dose got them stable in the first place.
Add-On for Major Depression
The extended-release version (Seroquel XR) is approved as an add-on treatment for major depressive disorder when antidepressants alone aren’t providing enough relief. The evidence here is real but modest. Across three randomized trials involving nearly 1,000 participants, adding quetiapine improved the chances of remission, with roughly 1 in 9 patients achieving remission who wouldn’t have on a placebo. The actual symptom improvement, measured on standard depression scales, translated to a small clinical effect.
Perhaps more telling: Seroquel did not improve quality of life compared to placebo in these short-term studies. A separate trial comparing it head-to-head with lithium augmentation (another common strategy for treatment-resistant depression) found similar effectiveness between the two. The tradeoff is side effects. In the depression trials, about 1 in 3 patients experienced sedation significant enough to be notable, and 1 in 6 developed abnormal metabolic lab results. Early discontinuation rates ran as high as 28% with quetiapine versus under 7% with placebo, suggesting many people found the side effects difficult to tolerate.
Off-Label Use for Insomnia
Low-dose Seroquel (often 25 to 100 mg) has become one of the most commonly prescribed medications for sleep problems, even though it has no approval for this use. In Canada, prescriptions for quetiapine by family physicians tripled between 2005 and 2012, driven largely by its use as a sleep aid. In the United States, quetiapine ranks as the fourth most frequently prescribed insomnia medication, behind the Z-drugs (like zolpidem), trazodone, and benzodiazepines. Up to 70% of all prescriptions for second-generation antipsychotics are written for conditions other than psychosis.
The medical consensus on this practice is cautious to negative. Multiple major organizations, including the American Diabetes Association, the American Psychiatric Association, and the American Geriatrics Society, have cautioned against using quetiapine off-label for sleep. Reviews of the available evidence consistently conclude that the data are insufficient to support its broad use for insomnia in the general population, particularly given the metabolic risks that accompany it even at low doses.
There are exceptions. For people who already have schizophrenia or a mood disorder, Seroquel’s sedating properties can be a useful bonus on top of its primary therapeutic role. Some evidence also supports its use for nightmares and insomnia related to PTSD. But for garden-variety insomnia in otherwise healthy people, the risk-to-benefit ratio is unfavorable.
Off-Label Use for Anxiety and PTSD
Seroquel is sometimes prescribed for anxiety disorders and PTSD, though the evidence base is limited. The 2023 VA/Department of Defense clinical practice guidelines take a neutral stance on quetiapine for PTSD, recommending neither for nor against its use. The evidence of benefit is classified as “very low,” and the guidelines note that any potential gains come alongside substantial risks of weight gain, blood sugar problems, and cholesterol abnormalities. For generalized anxiety disorder, quetiapine has shown some efficacy in trials, but it is not a guideline-recommended option given the availability of safer alternatives.
Weight Gain and Metabolic Effects
Weight gain is one of the most common and clinically significant side effects of Seroquel. In clinical studies, up to 23% of people with schizophrenia gained 7% or more of their body weight during treatment. For context, that means a 180-pound person would gain at least 12 to 13 pounds. The rates varied by condition: 21% for bipolar mania, 8% for bipolar depression, and 21% for adolescents with schizophrenia.
In the depression add-on trials, patients gained an average of about 2 pounds over just six to eight weeks of treatment. That may sound small, but it represents a trajectory. The metabolic effects extend beyond weight. Seroquel can raise blood sugar, increase cholesterol and triglycerides, and contribute to the cluster of risk factors known as metabolic syndrome. These risks exist even at the low doses used for sleep, which is a key reason medical organizations discourage casual prescribing for insomnia.
Other Common Side Effects
Sedation is the most immediately noticeable effect. In clinical trials for depression, the number needed to harm for sedation was just 3, meaning roughly one in every three people taking Seroquel experienced significant drowsiness beyond what placebo patients reported. This is a feature when the goal is sleep, but it’s a liability during waking hours. Many people experience a “hangover” feeling the morning after taking it, especially at higher doses.
Other frequently reported side effects include dry mouth, dizziness, constipation, and increased appetite. Seroquel can also cause orthostatic hypotension, a drop in blood pressure when standing up, particularly in the first few days of treatment or after dose increases. Less common but more serious risks include elevated blood sugar (even in people without diabetes), changes in thyroid function, and, rarely, a condition called neuroleptic malignant syndrome.
Dose Varies Widely by Condition
One of the more distinctive things about Seroquel is how dramatically the dose changes depending on what it’s being used for. At the low end, off-label sleep prescriptions often run 25 to 50 mg. Bipolar depression sits at 300 mg. Schizophrenia and bipolar mania typically require 400 to 800 mg. This wide dosing range means two people can be taking the same medication at doses that differ by a factor of 10 or more, targeting entirely different receptor systems at different levels of brain occupancy. The sedating effects are strongest at lower doses relative to the antipsychotic effects, which is partly why low-dose prescribing for sleep became so common despite the lack of formal approval for that use.